Blackbird CEO Ian McDonough ‘ready for scale up phase’ after fundraising. Read focusIR's Articles - London South East ...

(Sharecast News) - London stocks were set to fall at the open on Tuesday following a downbeat session on Wall Street, as investors continued to keep a close eye on tariff developments. The FTSE 100 ...

Mkango Resources Ltd. (AIM/TSX-V: MKA) has achieved a corporate milestone with first recycled rare earth alloy production in ...

(Alliance News) - Dunelm Group PLC on Monday named Clodagh Moriarty as its new chief executive officer, with effect from October 1.

(Alliance News) - MTI Wireless Edge Ltd on Monday said its antenna division has secured contracts worth around USD1.6 million for the supply of military antennas to three existing customers.

MTI Wireless Edge Ltd, up 6.4% at 47.89p, 12-month range 34.50p-70.90p. The technology company which manufactures antennas for military and commercial use wins contracts from three existing customers.

Oxford Instruments Share Chat. Chat About OXIG Shares - Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary.

(Sharecast News) - London stocks were set to fall at the open on Monday as the 9 July US tariff deadline looms. The FTSE 100 was called to open around 20 points lower.

Santander UK is the product of Santander's acquisition of UK mortgage lender Abbey National in 2004. It also includes the former Bradford & Bingley and Alliance & Leicester. TSB was sold by Lloyds ...

RBC raises TT Electronics price target to 120 (85) pence - 'sector perform' Deutsche Bank Research raises Ryanair price target to 27.50 (27) EUR - 'buy' Deutsche Bank Research raises Capita price ...

(Alliance News) - AFC Energy PLC on Friday said it has agreed to form a 50:50 joint venture with Industrial Chemicals Group Ltd to produce hydrogen from ammonia using its proprietary ammonia cracking ...

The Cambridge, England-based pharmaceutical company said Imfinzi has been approved in the EU for treatments in adults with resectable muscle-invasive bladder cancer. The approval is for the use of ...